California Public Employees Retirement System Decreases Holdings in Ventas, Inc. $VTR

California Public Employees Retirement System lowered its position in Ventas, Inc. (NYSE:VTR) by 10.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,086,136 shares of the real estate investment trust’s stock after selling 126,474 shares during the period. California Public Employees Retirement System’s holdings in Ventas were worth $88,824,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Capital World Investors acquired a new position in Ventas during the fourth quarter worth $594,116,000. Norges Bank purchased a new stake in Ventas during the fourth quarter worth $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Ventas by 32,509.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock valued at $359,722,000 after purchasing an additional 4,634,520 shares during the last quarter. Cohen & Steers Inc. grew its holdings in Ventas by 228.1% in the fourth quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock valued at $356,440,000 after purchasing an additional 3,202,323 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its position in shares of Ventas by 188.7% in the fourth quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock valued at $364,119,000 after buying an additional 3,075,450 shares in the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Price Performance

Shares of NYSE:VTR opened at $96.14 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The business’s fifty day moving average price is $87.26 and its two-hundred day moving average price is $84.19. The stock has a market cap of $46.74 billion, a PE ratio of 174.81, a price-to-earnings-growth ratio of 2.07 and a beta of 0.70. Ventas, Inc. has a one year low of $65.15 and a one year high of $97.16.

Ventas (NYSE:VTR) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the firm earned $0.84 earnings per share. The business’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts forecast that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is currently 378.18%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Jefferies Financial Group lifted their price target on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Raymond James Financial initiated coverage on shares of Ventas in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price objective on the stock. Scotiabank dropped their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Evercore restated an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. Finally, UBS Group lifted their target price on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

Insider Activity

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.53% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.